Sarah Cannon Cancer Network is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Sarah Cannon Cancer Network has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Solid Tumors, Triple Negative Breast Cancer (TNBC), Urothelial Cancer.
Sponsors: Adcentrx Therapeutics.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Cancer Network has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Cancer Network has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumors, Triple Negative Breast Cancer (TNBC), Urothelial Cancer.
Sarah Cannon Cancer Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.